Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. VRTX
VRTX logo

VRTX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VRTX News

Trump Bull Market May End, Three Stocks Still Poised to Rise

2d agoNASDAQ.COM

Prediction of the End of the Trump Bull Market

2d agoFool

Long-Term Investment Potential in Strong Healthcare Stocks

3d agoFool

Vertex Pharmaceuticals Shows Promising Future Prospects

5d agoFool

AvaíBio Initiates α-Klotho Cell Bank Creation

6d agoPRnewswire

AvaíBio Initiates Master Cell Bank for α-Klotho Production

6d agoNewsfilter

CRISPR Therapeutics: Financing and Future Prospects

Mar 23 2026Fool

CRISPR Raises $600 Million, Stock Price Pressured

Mar 23 2026NASDAQ.COM

CGUS Stock Price Analysis and ETF Dynamics

Mar 20 2026NASDAQ.COM

CRISPR Therapeutics Faces Challenges and Opportunities Ahead

Mar 20 2026Fool

CRISPR Therapeutics Faces Challenges and Opportunities Ahead

Mar 20 2026NASDAQ.COM

Three Drugmakers with Strong Market Potential

Mar 20 2026NASDAQ.COM

Pharmaceutical Industry Outlook: Eli Lilly, Vertex, and Pfizer

Mar 20 2026Fool

CNBC Launches Advocacy Platform for Rare Diseases

Mar 20 2026CNBC

Investment Outlook for Eli Lilly and Vertex Pharmaceuticals

Mar 19 2026Fool

Eli Lilly's Leadership in Weight Loss Market

Mar 19 2026NASDAQ.COM